Filter
285
Text search:
vaccine
candidates
Featured
Recommendations
33
New Publications
57
Language
Document type
No document type
99
Studies & Reports
62
Guidelines
46
Fact sheets
30
Resource Platforms
12
Strategic & Response Plan
12
Manuals
10
Videos
6
Situation Updates
4
Online Courses
3
Training Material
1
Countries / Regions
Global
16
West and Central Africa
10
India
9
East and Southern Africa
8
Middle East and North Africa
7
Sierra Leone
6
Liberia
6
Africa
6
Russia
6
Nigeria
5
Latin America and the Carribbean
5
Guinea
4
Germany
4
Kenya
4
China
4
South Africa
4
Uganda
3
South Sudan
3
Tanzania
3
Ukraine
3
USA
2
Ethiopia
2
Ghana
2
Haiti
2
Philippines
2
Nepal
2
Syria
2
Brazil
2
Myanmar / Burma
2
Congo, Democratic Republic of
1
Zambia
1
Turkey
1
Thailand
1
Rwanda
1
Indonesia
1
Bangladesh
1
Mozambique
1
North Macedonia
1
Madagascar
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Timor Leste/ East Timor
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
70
Clinical Guidelines
32
Public Health
10
Women & Child Health
4
Key Resources
3
Pharmacy & Technologies
3
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
105
TB
24
Rapid Response
17
Ebola
16
HIV
10
NTDs
9
AMR
8
Health Financing Toolbox
8
Zika
6
Polio
4
Global Health Education
4
Cholera
2
Conflict
2
Refugee
2
Caregiver
2
Planetary Health
2
Pharmacy
2
Disability
1
Natural Hazards
1
Mental Health
1
NCDs
1
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a
...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec
...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key informat
...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate v
...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine developm
...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing
...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing
...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G
...
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation of vaccine hesitanc
...
